Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Condition: PediculosisInterventions: Drug: Malathion gel 0.5%; Drug: Permethrin 1% rinse (Nix Crème)Sponsor: Taro Pharmaceuticals USACompleted - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2009 Category: Research Source Type: clinical trials
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Condition: PediculosisInterventions: Drug: Malathion gel 0.5%; Drug: Permethrin 1% rinse (Nix Crème)Sponsor: Taro Pharmaceuticals USACompleted - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2009 Category: Research Source Type: clinical trials
Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice
Condition: PediculosisInterventions: Drug: Malathion gel 0.5%; Drug: Malathion lotion 0.5%Sponsor: Taro Pharmaceuticals USACompleted - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2009 Category: Research Source Type: clinical trials